Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype
The Power of Discovery: GLP-1 Receptor Agonists November 11, 2025 Baton Rouge, LA For years, Pennington Biomedical Research Center has been instrumental in GLP-1 drug research Life-changing medications dont happen overnight
In my 13 years of experience, Ive learned thisdont jump on the biggest and the newest trends
3lp), but rather improves liver and cardiovascular health with slightly greater efficacy than GLP-1RGIPR co-agonism (Fig
We have organized political actions leading toward local and national mass mobilizations on racism, self-determination, reparations, quality health care, housing, criminal justice, and education
Liver fat concentration, the prevalence of nonalcoholic fatty liver disease (NAFLD), and visceral adipose tissue (VAT) were investigated